In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization

Carolina Serena, Montserrat Ortoneda, Javier Capilla, F. Javier Pastor, Deanna A. Sutton, Michael G. Rinaldi, Josep Guarro

Research output: Contribution to journalArticlepeer-review

41 Scopus citations


Chaetomium is an unusual etiological agent of human infections, but the mortality rate among immunocompromised patients is considerably greater than that among nonimmunocompromised individuals. We investigated the in vitro antifungal susceptibilities to novel antifungal agents of 19 strains belonging to three species of Chaetomium which have been involved in human infections, i.e., Chaetomium globosum, C. atrobrunneum, and C. nigricolor, and one strain of the closely related species Achaetomium strumarium. A modification of the NCCLS reference microdilution method (M38-A) was used to evaluate the in vitro activities of ravuconazole, voriconazole, albaconazole, and micafungin. Micafungin was not active at all, while the geometric mean MICs and minimum effective concentrations of the three triazoles were less than 0.5 and 0.4 μg/ml, respectively.

Original languageEnglish (US)
Pages (from-to)3161-3164
Number of pages4
JournalAntimicrobial agents and chemotherapy
Issue number10
StatePublished - Oct 1 2003

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases


Dive into the research topics of 'In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization'. Together they form a unique fingerprint.

Cite this